GlassScriptPhysician profile
Heather Buttrum
NPI 1033738901
$1,367.61
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.13 · 2022: $549 · 2023: $541 · 2024: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $196.65 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $167.27 | 2022-2023 | |
| Amgen INC. | $153.48 | 2022-2023 | Repatha, Otezla, Prolia |
| Abbvie INC. | $153.35 | 2022-2023 | |
| Medtronic, INC. | $125.78 | 2022-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Bayer Healthcare Pharmaceuticals INC. | $97.55 | 2022-2024 | |
| Pfizer INC. | $85.19 | 2023-2024 | |
| Exact Sciences Corporation | $61.61 | 2023-2024 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $49.52 | 2022-2023 | |
| Abbott Laboratories | $40.19 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Biohaven Pharmaceutical Holding Company LTD. | $39.17 | 2022 | |
| Lilly USA, LLC | $37.35 | 2022-2023 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $28.00 | 2023 | Quviviq |
| Impel Pharmaceuticals INC. | $25.43 | 2022 | |
| Mylan Specialty L.P. | $20.02 | 2023 | Yupelri |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $19.91 | 2023 | Doc Band |
| Edwards Lifesciences Corporation | $17.66 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $16.94 | 2022 | |
| Aimmune Therapeutics, INC. | $16.38 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Buttrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.